Twin Focus Capital Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,785
Closed -$260K 221
2022
Q4
$260K Buy
2,785
+29
+1% +$2.8K 0.05% 174
2022
Q3
$263K Buy
2,756
+81
+3% +$8.02K 0.06% 162
2022
Q2
$248K Buy
2,675
+22
+0.8% +$2.15K 0.06% 165
2022
Q1
$269K Buy
2,653
+106
+4% +$11.1K 0.05% 179
2021
Q4
$263K Buy
+2,547
New +$235K 0.05% 183
2016
Q2
Sell
-2,193
Closed -$227K 84
2016
Q1
$227K Sell
2,193
-1
-0% -$97 0.21% 63
2015
Q4
$215K Buy
2,194
+3
+0.1% +$294 0.22% 75
2015
Q3
$211K Sell
2,191
-36
-2% -$3.79K 0.27% 68
2015
Q2
$234K Sell
2,227
-572
-20% -$58.4K 0.26% 70
2015
Q1
$289K Buy
2,799
+81
+3% +$8.2K 0.23% 60
2014
Q4
$262K Sell
2,718
-251
-8% -$22.1K 0.31% 73
2014
Q3
$236K Buy
+2,969
New +$234K 0.23% 81

Other funds holding CVS

Twin Focus Capital Partners's CVS Position: Q1 2023 in Review

Twin Focus Capital Partners sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,785 shares — an estimated $260K sold.

Twin Focus Capital Partners first reported a position in CVS in Q3 2014 and held it in 12 quarters. The position peaked at $289K in Q1 2015. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Twin Focus Capital Partners reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Twin Focus Capital Partners sold 2,785 CVS Health shares in Q1 2023, an estimated $260K.
  • Twin Focus Capital Partners first reported a position in CVS Health in Q3 2014 and held it in 12 quarters.
  • Twin Focus Capital Partners's CVS Health position peaked at $289K in Q1 2015.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Twin Focus Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.